COVID-19 drug and vaccine patents are putting profit before people
Ronald Labonté, Mira Johri
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Business2019-20 coronavirus outbreakVirologyFor profitDrugMedicineFinanceInfectious disease (medical specialty)PharmacologyOutbreakInternal medicineDiseaseScience, Research, and Medicine